Clinical Trial Update: Autologous Bedside CD19 CAR T-cell Therapy for B-ALL [EARLY_Phase 1]

View source ↗

Summary

An early-phase trial of autologous bedside CD19 CAR T-cell therapy for adult B-cell acute lymphoblastic leukemia is underway. The study is currently not yet rec…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• B-cell Acute Lymphoblastic Leukemia

Drugs mentioned

• CD19 CAR T-cell therapy (autologous bedside) (CD19-targeted CAR T-cell therapy)

Snippet

Sponsor: The General Hospital of Western Theater Command | Conditions: B-Cell Acute Lymphoblastic Leukemia, Adult | EARLY_Phase 1 | Status: NOT_YET_RECRUITING